Product: | Propranolol-d7 (ring-d7) | ||||||||
---|---|---|---|---|---|---|---|---|---|
Catalog Number: | D422 | ||||||||
CAS Number: | 344298-99-3 | ||||||||
Synonyms: |
(±)-Propranolol-d7 (ring-d7); (±)-1-[(1-Methylethyl)amino]-3-(1-naphthalenyloxy)-2-propanol-d7; (±)-1-[2-Hydroxy-3-[(1-methylethyl)-amino]-propoxy]naphthalene-d7; (±)-1-Isopropylamino-3-(1-naphthyloxy)-2-propanol-d7 |
||||||||
Pricing: |
|
||||||||
Formula: | C16H21D7NO2 | ||||||||
Enrichment: | 97-98%D | ||||||||
Molecular Weight: | 266.39 | ||||||||
Structure: | |||||||||
Appearance: | White solid | ||||||||
Category: | Research Compounds | ||||||||
Stability: | Stable under recommended storage conditions | ||||||||
Storage: |
Store at room temperature. Adequate ventilation. Protect from light. Protect from moisture |
||||||||
Transportation: |
Non-hazardous for transport |
||||||||
Literature References: |
Black JW, Crowther AF, Shanks RG, Smith LH, Dornhorst AC, A new adrenergic betareceptor antagonist. The Lancet, 1964, 283 (7342): 1080–1081.; Shields, Kevin G.; Peter J. Goadsby, Propranolol modulates trigeminovascular responses in thalamic ventroposteromedial nucleus: a role in migraine? Brain, 2005, 128 (1): 86–97. |
||||||||
MSDS: | |||||||||
Applications: | A labeled sympatholytic nonselective beta blocker. Used to treat high blood pressure, heart dysrhythmias, thyrotoxicosis, and essential tremors. Also used to prevent migraine headaches and to prevent further problem in patients with angina or who have had a heart attack previously. |